299 related articles for article (PubMed ID: 30016071)
1. Nanocarrier-Mediated Chemo-Immunotherapy Arrested Cancer Progression and Induced Tumor Dormancy in Desmoplastic Melanoma.
Liu Q; Chen F; Hou L; Shen L; Zhang X; Wang D; Huang L
ACS Nano; 2018 Aug; 12(8):7812-7825. PubMed ID: 30016071
[TBL] [Abstract][Full Text] [Related]
2. Nano-delivery of fraxinellone remodels tumor microenvironment and facilitates therapeutic vaccination in desmoplastic melanoma.
Hou L; Liu Q; Shen L; Liu Y; Zhang X; Chen F; Huang L
Theranostics; 2018; 8(14):3781-3796. PubMed ID: 30083259
[No Abstract] [Full Text] [Related]
3. Remodeling the fibrotic tumor microenvironment of desmoplastic melanoma to facilitate vaccine immunotherapy.
Zhu H; Liu Q; Miao L; Musetti S; Huo M; Huang L
Nanoscale; 2020 Feb; 12(5):3400-3410. PubMed ID: 31989142
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle-Mediated Trapping of Wnt Family Member 5A in Tumor Microenvironments Enhances Immunotherapy for B-Raf Proto-Oncogene Mutant Melanoma.
Liu Q; Zhu H; Tiruthani K; Shen L; Chen F; Gao K; Zhang X; Hou L; Wang D; Liu R; Huang L
ACS Nano; 2018 Feb; 12(2):1250-1261. PubMed ID: 29370526
[TBL] [Abstract][Full Text] [Related]
5. Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy.
Yang W; Zhang F; Deng H; Lin L; Wang S; Kang F; Yu G; Lau J; Tian R; Zhang M; Wang Z; He L; Ma Y; Niu G; Hu S; Chen X
ACS Nano; 2020 Jan; 14(1):620-631. PubMed ID: 31877023
[TBL] [Abstract][Full Text] [Related]
6. Celastrol Self-Stabilized Nanoparticles for Effective Treatment of Melanoma.
Li J; Jia Y; Zhang P; Yang H; Cong X; An L; Xiao C
Int J Nanomedicine; 2020; 15():1205-1214. PubMed ID: 32110017
[TBL] [Abstract][Full Text] [Related]
7. Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway.
Lu J; Liu X; Liao YP; Wang X; Ahmed A; Jiang W; Ji Y; Meng H; Nel AE
ACS Nano; 2018 Nov; 12(11):11041-11061. PubMed ID: 30481959
[TBL] [Abstract][Full Text] [Related]
8. ZnO-based multifunctional nanocomposites to inhibit progression and metastasis of melanoma by eliciting antitumor immunity via immunogenic cell death.
Zhang Y; Guo C; Liu L; Xu J; Jiang H; Li D; Lan J; Li J; Yang J; Tu Q; Sun X; Alamgir M; Chen X; Shen G; Zhu J; Tao J
Theranostics; 2020; 10(24):11197-11214. PubMed ID: 33042278
[No Abstract] [Full Text] [Related]
9. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy.
Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D
ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771
[TBL] [Abstract][Full Text] [Related]
10. Plasmon-Driven Catalytic Chemotherapy Augments Cancer Immunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
Ding Y; Sun Z; Gao Y; Zhang S; Yang C; Qian Z; Jin L; Zhang J; Zeng C; Mao Z; Wang W
Adv Mater; 2021 Aug; 33(34):e2102188. PubMed ID: 34278622
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria-targeted polyprodrug nanoparticles induce mitochondrial stress for immunogenic chemo-photodynamic therapy of ovarian cancer.
Zhang W; Chen G; Chen Z; Yang X; Zhang B; Wang S; Li Z; Yang Y; Wu Y; Liu Z; Yu Z
J Control Release; 2024 Jul; 371():470-483. PubMed ID: 38849094
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
13. Blockage of the IDO1 pathway by charge-switchable nanoparticles amplifies immunogenic cell death for enhanced cancer immunotherapy.
Shi M; Zhang J; Wang Y; Han Y; Zhao X; Hu H; Qiao M; Chen D
Acta Biomater; 2022 Sep; 150():353-366. PubMed ID: 35843594
[TBL] [Abstract][Full Text] [Related]
14. Nanocarrier-Mediated Immunogenic Cell Death for Melanoma Treatment.
Wang J; Ma J; Tai Z; Li L; Zhang T; Cheng T; Yu J; Zhu Q; Bao L; Chen Z
Int J Nanomedicine; 2023; 18():7149-7172. PubMed ID: 38059000
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine nanoparticles promote antitumor immunity against melanoma.
Zhang Y; Bush X; Yan B; Chen JA
Biomaterials; 2019 Jan; 189():48-59. PubMed ID: 30388589
[TBL] [Abstract][Full Text] [Related]
16. A Nanoplatform to Amplify Apoptosis-to-Pyroptosis Immunotherapy via Immunomodulation of Myeloid-Derived Suppressor Cells.
Zhou S; Shang Q; Ji J; Luan Y
ACS Appl Mater Interfaces; 2021 Oct; 13(40):47407-47417. PubMed ID: 34597015
[TBL] [Abstract][Full Text] [Related]
17. Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment.
Huo M; Zhao Y; Satterlee AB; Wang Y; Xu Y; Huang L
J Control Release; 2017 Jan; 245():81-94. PubMed ID: 27863995
[TBL] [Abstract][Full Text] [Related]
18. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
19. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
[TBL] [Abstract][Full Text] [Related]
20. Betulinic acid in complex with a gamma-cyclodextrin derivative decreases proliferation and in vivo tumor development of non-metastatic and metastatic B164A5 cells.
Soica C; Danciu C; Savoiu-Balint G; Borcan F; Ambrus R; Zupko I; Bojin F; Coricovac D; Ciurlea S; Avram S; Dehelean CA; Olariu T; Matusz P
Int J Mol Sci; 2014 May; 15(5):8235-55. PubMed ID: 24821543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]